BIO International Convention, the most important partnering meeting of the international biotechnology sector, was held in the city of Boston from June 4 to 7, 2018. The Spanish pavilion was common to all companies, including the Catalan ones, which managed their presence through ICEX.
The participation model has changed in 2018 and ICEX pavilion (stand number 543) was common for all Spanish companies, regardless of the bioregion from which they come. Biocat attended the fair and contributed to the diffusion of the Catalan presence in Boston, but not coordinated the delegation or acted as an interlocutor with ICEX.
ICEX offered two types of participation -with and without stand- and both included the Convention Access & Partnering ticket, the most complete of the fair, which allows access to the partnering system and arrange meetings in the Business Forum, as well as giving access to everything the program. So, as it happened in the last editions, there was no partnering inside the pavilion, but in the Business Forum area.
Check the program of the 2018 convention and other relevant aspects on the BIO International Convention website.
As in the last editions, ICEX held an official kick-off that took take place on Monday June 4 from 08:00 to 1:00 p.m. at Seaport Hotel in Boston, the "At the cutting Edge" Technical Conference - Challenges, successes and lessons learned at the Forefront of biotech innovation, licensing and venture ", that allowed the encounter between Spanish companies and American companies and institutions in the sector. Among the keynote speakers were Joseph Damon (Executive VP International Affairs, BIO) and Pedro Morenés (Spain's ambassador to the US) and the participation of two Catalan companies: Bioseed Capital, with the intervention of Juan García Soria (Managing Partner ) and ProteoDesign with the presentation of Miquel Vila-Perelló (Managing Director & CSO). Check the complete ICEX kick-off program.
For more information, see the updated study "El mercado de la biotecnología en los Estados Unidos", published by the Economic and Commercial Office of Spain in Chicago.
Additionally, on Monday took place the International Cancer Cluster Showcase from 12:30 p.m. to 4:30 p.m. where two Catalan companies presented their most innovative projects in the field of oncology: ASCIL Biopharm and IDP Discovery Pharma. The program included a coffee break with an exhibition of posters and presentations of clusters and companies.
Furthermore, as in previous editions, the stand of the SpainBio pavilion hosted the Hospitality Reception on Tuesday, June 5 from 5:00 p.m. to 6:30 p.m. (Boston Convention & Exhibition Center (BCEC) booth #543).
37 companies from the biotechnological and pharmaceutical sectors and research centers and entities were present at the fair. Of these, 4 companies (ASCIL Biopharm, Cytes Biotechnologies, Laboratorios SALVAT and Barcelona Science Park) had their own space within the SpainBio pavilion (# 543), and the company Grifols participated with an independent stand within the fair space (# 1149). Find below a table of the Catalan companies that attended the event, either with the official delegation or on their own:
Biotechnology - Therapeutics & Diagnostics:
Biotechnology - R&D Services:
Professional Services and Consulting:
The 2017 edition of this fair -celebrated in San Diego with the participation of 30 Catalan companies and institutions- brought together more than 16,000 delegates from 74 countries and led to more than 41,000 partnering meetings. Thus, the BIO is a great opportunity to reach senior executives and decision-makers who attend the convention and to discover new industry players, forge collaborations and evaluate emerging technologies.
Learn more about the fair through the infographic of BIO San Diego 2017.
Venue: Boston Convention & Exhibition Center (BCEC) ·415 Summer St, Boston, Ma 02210, USA
With the support of: